Boxer Capital

Boxer Capital

Boxer Capital

Tavistock Group is an international private investment organization founded by Joe Lewis more than 40 years ago and built on a core philosophy: We strive for excellence in everything we do.
Suggest edits
Follow us
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 17

Portfolio

Portfolio Tracker

Add info
Add round
23 Sep 2020
Silverback Therapeutics
Silverback Therapeutics
$85,000,000
Venture capital (Series C)
OrbiMed Advisors, EcoR1 Capital, Boxer Capital, +6

Silverback Therapeutics Raises $85M in Series C Financing

FinSMEs
+1
25 Aug 2020
Connect Biopharmaceuticals
Connect Biopharmaceuticals
$115,000,000
Venture capital (Series C)
RA Capital Management, QiMing Venture Partners, HBM Healthcare Investments, +2

Clinical-Stage Biopharmaceutical Company Connect Biopharma Raises $115 Million

Pulse 2.0
+1
17 Aug 2020
Tango Therapeutics
Tango Therapeutics
$50,000,000
Venture capital
Casdin Capital, Cormorant Asset Management, Boxer Capital, +1

Tango Therapeutics Raises $50M in Equity Financing

FinSMEs
23 Jul 2020
Encoded Genomics Inc
Encoded Genomics Inc
$135,000,000
Venture capital (Series D)
Menlo Ventures, ARCH Venture Partners, Matrix Capital Management, +9

Encoded Therapeutics Raises $135M in Series D Financing

FinSMEs
+1
15 Jul 2020
BioAtla, LLC
BioAtla, LLC
$72,500,000
Venture capital (Series D)
Cormorant Asset Management, Boxer Capital, Farallon Capital Management, +5

BioAtla Raises $72.5M In Series D Financing

FinSMEs
12 Apr 2020
Tango Therapeutics
Tango Therapeutics
$60,000,000
Venture capital (Series B)
Casdin Capital, Cormorant Asset Management, Boxer Capital

Targeted Cancer Therapies Company Tango Closes $60 Million

Pulse 2.0
13 Jan 2020
Tyra Biosciences
Tyra Biosciences
$50,000,000
Venture capital (Series A)
RA Capital Management, Alta Partners, Boxer Capital, +2

Tyra Biosciences Raises USD 50M in Series A Funding

FinSMEs
22 Apr 2019
Poseida Therapeutics
Poseida Therapeutics
$142,000,000
Venture capital (Series C)
Aisling Capital, Novartis, Perceptive Advisors, +6
06 Jan 2019
Cabaletta Bio
Cabaletta Bio
$50,000,000
Venture capital (Series B)
Redmile Group, Adage Capital Management, 5AM Ventures, +3

Cabaletta Bio closes $50M Series B round for cell-based autoimmune disease therapies

MedCity News
+1
04 Jan 2019
Sojournix
Sojournix
$44,000,000
Venture capital (Series C)
RA Capital Management, Frazier Healthcare Partners, Boxer Capital, +2
25 Oct 2018
Milestone Pharmaceuticals, Inc.
Milestone Pharmaceuticals, Inc.
$80,000,000
Venture capital
Fonds de solidarité FTQ, Domain Associates, BDC Capital, +8

Milestone Pharmaceuticals Raises $80M in Equity Funding

FinSMEs
16 Sep 2018
Atreca, Inc.
Atreca, Inc.
$125,000,000
Venture capital (Series C)
Redmile Group, Aisling Capital, EcoR1 Capital, +5

Atreca Raises $125M in Series C Funding

FinSMEs
+2
15 Mar 2018
IDEAYA Biosciences
IDEAYA Biosciences
$94,000,000
Venture capital (Series B)
Canaan Partners, Roche Venture Fund, 5AM Ventures, +10

Ideaya Biosciences Raises $94M Crossover Series B Financing

FinSMEs
08 Mar 2018
Prevail Therapeutics
Prevail Therapeutics
$75,000,000
Venture capital (Series A)
Adage Capital Management, RA Capital Management, OrbiMed, +6

Prevail Gets $75M For Parkinson’s Gene Therapy, Bolstering NY Biotech

Xconomy
+1
26 Sep 2017
GTx, Inc.
GTx, Inc.
$48,500,000
Post-IPO equity
Aisling Capital, Abingworth, Boxer Capital, +2
05 Jan 2017
CiVi Biopharma
CiVi Biopharma
$40,000,000
Venture capital (Series A)
Boxer Capital

CiVi Biopharma Raises $40 Million in Series A Financing From Boxer Capital of the Tavistock Group

prnewswire
08 Sep 2015
AveXis
AveXis
$65,000,000
Venture capital (Series D)
Adage Capital Management, Foresite Capital, RA Capital Management, +9

AveXis Completes $65M Series D Financing

FinSMEs